Title : Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer.

Pub. Date : 2022 Jan-Dec

PMID : 35168393






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In RKO cells, lovastatin showed similar inhibitory properties as the RhoA inhibitor CCG1423, being able to inhibit beta-catenin, TAZ, and p-LATS1 protein activity. CCG 1423 catenin beta 1 Homo sapiens